Total and cause-specific mortality by moderately and markedly increased ferritin concentrations: General population study and metaanalysis

Clinical Chemistry

Volumn 60, Issue 11, 2014, Pages 1419-1428

  Ellervik, Christina ^a,b   Marott, Jacob Louis ^c   Tybjærg Hansen, Anne ^b,c,d   Schnohr, Peter ^c   Nordestgaard, Børge G ^b,c,e  

^a NYKØBING FALSTER HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c FREDERIKSBERG HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PREDICTION; RISK ASSESSMENT; SURVIVAL TIME; AGED; BLOOD; COHORT ANALYSIS; DENMARK; EPIDEMIOLOGY; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; META ANALYSIS; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; DENMARK; FEMALE; FERRITINS; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS; YOUNG ADULT;

EID: 84908611438     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.229013     Document Type: Article

References (40)

1. Adams PC, Barton JC. A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation. J Hepatol 2011;55:453-8.
2. Waalen J, Felitti VJ, Gelbart T, Beutler E. Screening for hemochromatosis by measuring ferritin levels: a more effective approach. Blood 2008; 111:3373-6.
3. Jenq CC, Hsu CW, Huang WH, Chen KH, Lin JL, Lin-Tan DT. Serum ferritin levels predict all-cause and infection-cause 1-year mortality in diabetic patients on maintenance hemodialysis. Am J Med Sci 2009;337:188-94.
4. Nadjar Y, Gordon P, Corcia P, Bensimon G, Pieroni L, Meininger V, Salachas F. Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosis. PLoS One 2012;7: e45034.
5. Depalma RG, Hayes VW, Chow BK, Shamayeva G, May PE, Zacharski LR. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial. J Vasc Surg 2010;51:1498-503.
6. MacPhail AP, Mandishona EM, Bloom PD, Paterson AC, Rouault TA, Gordeuk VR. Measurements of iron status and survival in African iron overload. S Afr Med J 1999;89:966-72.
7. Gordeuk VR, Onojobi G, Schneider MF, Dawkins FW, Delapenha R, Voloshin Y et al. The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection. Haematologica 2006;91:739-43.
8. McDermid JM, Jaye A, Schim van der Loeff MF, Todd J, Bates C, Austin S et al. Elevated iron status strongly predicts mortality in West African adults with HIV infection. J Acquir Immune Defic Syndr 2007;46:498-507.
9. Sempos CT, Looker AC, Gillum RE, Mcgee DL, Vuong CV, Johnson CL. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study. Ann Epidemiol 2000;10:441-8.
10. Menke A, Muntner P, Fernandez-Real JM, Guallar E. The association of biomarkers of iron status with mortality in US adults. Nutr Metab Cardiovasc Dis 2012;32:734-40.
11. Marniemi J, Jarvisalo J, Toikka T, Raiha I, Ahotupa M, Sourander L. Blood vitamins, mineral elements and inflammation markers as risk factors of vascular and non-vascular disease mortality in an elderly population. Int J Epidemiol 1998; 27:807.
12. Barton JC, Barton JC, Acton RT, So J, Chan S, Adams PC. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 mug/L at diagnosis. Clin Gastroenterol Hepatol 2012;10:412-6.
13. Pietrangelo A. Hereditary hemochromatosis-a new look at an old disease. N Engl J Med 2004; 350:2383-97.
14. Hsu HS, Li CI, Liu CS, Lin CC, Huang KC, Li TC et al. Iron deficiency is associated with increased risk for cardiovascular disease and all-cause mortality in the elderly living in long-term care facilities. Nutrition 2013;29:737-43.
15. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999; 28:964-74.
16. Aleman S, Endalib S, Stal P, Loof L, Lindgren S, Sandberg-Gertzen H et al. Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population. Scand J Gastroenterol 2011;46: 1118-26.
17. Friedrich N, Milman N, Volzke H, Linneberg A, Jorgensen T. Is serum ferritin within the reference range a risk predictor of cardiovascular disease? A population-based, long-term study comprising 2874 subjects. Br J Nutr 2009;102:594-600.
18. Mainous AG, III, Gill JM, Pearson WS. Should we screen for hemochromatosis? An examination of evidence of downstream effects on morbidity and mortality. Arch Intern Med 2002;162:1769-74.
19. Stevens RG, Kuvibidila S, Kapps M, Friedlaender J, Blumberg BS. Iron-binding proteins, hepatitis B virus, and mortality in the Solomon Islands. Am J Epidemiol 1983;118:550-61.
20. Egger M, Smith GD, Altman DG. Systematic reviews in health care. London: BMJ Books; 2003.
21. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006;11:193-206.
22. Jannerfeldt E, Horte LG. Median age at death as an indicator of premature mortality. Br Med J (Clin Res Ed) 1988;296:678-81.
23. Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG. Total mortality by transferrin saturation levels: two general population studies and a metaanalysis. Clin Chem 2011;57:459-66.
24. Ellervik C, Andersen HU, Tybjærg Hansen A, Frandsen M, Birgens H, Nordestgaard BG, Mandrup-Poulsen T. Total mortality by elevated transferrin saturation in patients with diabetes. Diabetes Care 2013;36:2646-54.
25. Ellervik C, Mandrup-Poulsen T, Tybjaerg-Hansen A, Nordestgaard BG. Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes: two general population studies. Diabetes Care 2014;37:444-52.
26. Mursu J, Robien K, Harnack LJ, Park K, Jacobs DR Jr. Dietary Supplements and mortality rate in older women: the Iowa Women's Health Study. Arch Intern Med 2011;171:1625-33.
27. Danesh J, Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 1999;99:852-4.
28. Ellervik C, Tybjaerg-Hansen A, Appleyard M, Ibsen H, Nordestgaard BG. Haemochromatosis genotype and iron overload: association with hypertension and left ventricular hypertrophy. J Intern Med 2010;268:252-64.
29. James T. Pathology of the cardiac conduction system in hemochromatosis. N Engl J Med 1964; 271:92-4.
30. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
31. Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG. Risk of cancer by transferrin saturation levels and haemochromatosis genotype: population-based study and meta-analysis. J Intern Med 2011;271: 51-63.
32. Ellervik C, Mandrup-Poulsen T, Andersen HU, Tybjaerg-Hansen A, Frandsen M, Birgens H, Nordestgaard BG. Elevated transferrin saturation and risk of diabetes: three population-based studies. Diabetes Care 2011;34:2256-8.
33. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem 2005;12: 1161-208.
34. Broedbaek K, Poulsen HE, Weimann A, Kom GD, Schwedhelm E, Nielsen P, Boger RH. Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis. Free Radic Biol Med 2009;47:1230-3.
35. Sennels HP, Jorgensen HL, Hansen AL, Goetze JP, Fahrenkrug J. Diurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variations. Scand J Clin Lab Invest 2011;71:532-41.
36. Adult Treatment Panel III. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
37. Pedersen CB. The Danish civil registration system. Scand J Public Health 2011;39:22-5.
38. Helweg-Larsen K. The Danish register of causes of death. Scand J Public Health 2011;39:26-9.
39. Roulson J, Benbow EW, Hasleton PS. Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a metaanalysis and review. Histopathology 2005;47: 551-9.
40. Lahti RA, Penttila A. Cause-of-death query in validation of death certification by expert panel; effects on mortality statistics in Finland, 1995. Forensic Sci Int 2003;131:113-24.